CJC-1295 with DAC and GHRP-2 Interaction

Synergistic
Mechanism-based 55% confidence

CJC-1295 with DAC and GHRP-2 have a synergistic interaction with 55% confidence. CJC-1295 with DAC and GHRP-2 amplify GH release through complementary mechanisms (GHRH primes, GHRP triggers). This is a well-established synergistic combination — expect significantly greater GH output than either alone. Both compounds affect the gi tract and pituitary, so monitoring these systems is recommended.

Compound Profiles

CJC-1295 with DAC

Long-Acting Growth Hormone Releasing Hormone Analog | Extended Release

DAC binds to albumin, extending half-life to 6-8 days and providing continuous GHRH receptor stimulation for sustained GH/IGF-1 elevation..

Half-life: 6-8 days Typical dose: 1-2mg weekly growth hormone, weight loss
ghrh receptorigf1 carcinogenic riskestrogenicinsulin disrupting
View full profile

GHRP-2

Growth Hormone Releasing Peptide-2 | Pralmorelin

GHRP-2 acts as a synthetic agonist of ghrelin, binding to the growth hormone secretagogue receptor (GHS-R1a) in the hypothalamus and pituitary. This stimulates cAMP production and promotes pulsatile release of endogenous growth hormone without suppressing natural feedback loops.

Half-life: ~30 minutes Typical dose: 100-300 mcg growth hormone, weight loss
ghrelin receptor carcinogenic riskinsulin disruptingprolactin elevatingteratogenic
View full profile

Combined Organ Load

GI Tract
low
Pituitary
low

Shared Safety Flags

2x 2 compounds share the carcinogenic-risk safety flag (CJC-1295 with DAC, GHRP-2). Monitor accordingly.
2x 2 compounds affect insulin sensitivity (CJC-1295 with DAC, GHRP-2). Monitor fasting glucose and HbA1c.

Frequently Asked Questions

Can I take CJC-1295 with DAC with GHRP-2?

Yes, CJC-1295 with DAC and GHRP-2 can generally be taken together. CJC-1295 with DAC and GHRP-2 amplify GH release through complementary mechanisms (GHRH primes, GHRP triggers). This is a well-established synergistic combination — expect significantly greater GH output than either alone.

Is CJC-1295 with DAC and GHRP-2 safe together?

Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: carcinogenic risk, insulin disrupting. Monitor accordingly.

What are the interactions between CJC-1295 with DAC and GHRP-2?

CJC-1295 with DAC and GHRP-2 amplify GH release through complementary mechanisms (GHRH primes, GHRP triggers). This is a well-established synergistic combination — expect significantly greater GH output than either alone. This assessment has 55% confidence and is inferred from pharmacological mechanism analysis.

How should I time CJC-1295 with DAC and GHRP-2?

CJC-1295 with DAC has a half-life of 6-8 days and GHRP-2 has a half-life of ~30 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: CJC-1295 with DAC vs GHRP-2

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.